基本信息
浏览量:0
职业迁徙
个人简介
暂无内容
研究兴趣
论文共 23 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Koh Izumiyama,Tasuku Inao,Hideki Goto,Shinpei Harada,Hajime Senjo,Keito Suto,Junichi Hashiguchi,Reiki Ogasawara,Tomoyuki Saga,Tetsuyuki Igarashi,Kentaro Wakasa,Ikumi Kasahara,Yukari Takeda,Keisuke Yamaguchi,Akio Shigematsu,Mutsumi Takahata,Katsuya Fujimoto,Yoshihito Haseyama,Takahiro Nagashima,Hajime Sakai,Yasutaka Kakinoki,Mitsutoshi Kurosawa,Isao Yokota,Takanori Teshima
Shinpei Harada,Hideki Goto,Hajime Senjo,Keito Suto,Koh Izumiyama,Masayo Yamamoto,Kazuya Sato,Yasutaka Kakinoki,Tomoyuki Saga,Akio Shigematsu,Hiroto Horiguchi,Mutsumi Takahata,Reiki Ogasawara,Satoshi Yamamoto,Keisuke Yamaguchi,Kentaro Wakasa,Tetsuyuki Igarashi,Yoshihito Haseyama,Shinichi Ito,Katsuya Fujimoto, Junichi Hashiguchi,Masao Nakagawa,Daigo Hashimoto, Takanori Teshima
Bloodno. Supplement 1 (2023): 440-440
HemaSphereno. S3 (2023): e91452b7-e91452b7
Shinpei Harada,Hideki Goto,Hajime Senjo,Keito Suto,Shiro Watanabe,Koh Izumiyama,Masayo Yamamoto,Kazuya Sato,Yasutaka Kakinoki,Tomoyuki Saga,Akio Shigematsu,Hiroto Horiguchi,Mutsumi Takahata,Reiki Ogasawara,Satoshi Yamamoto,Keisuke Yamaguchi,Kentaro Wakasa,Tetsuyuki Igarashi,Yoshihito Haseyama,Shinichi Ito,Katsuya Fujimoto,Junichi Hashiguchi,Masao Nakagawa,Daigo Hashimoto,Takanori Teshima
Bloodno. Supplement 1 (2023): 6321-6321
BLOOD (2023)
BONE MARROW TRANSPLANTATIONno. SUPP1 (2023): 68-69
引用0浏览0引用
0
0
Blood (2023): 97
Shinpei Harada,Hideki Goto,Hajime Senjo,Keito Suto,Shiro Watanabe,Yuko Uchiyama,Koh Izumiyama,Masayo Yamamoto,Kazuya Sato,Yasutaka Kakinoki,Tomoyuki Saga,Akio Shigematsu,Hiroto Horiguchi,Mutsumi Takahata,Reiki Ogasawara,Satoshi Yamamoto,Keisuke Yamaguchi,Kentaro Wakasa,Tetsuyuki Igarashi,Yoshihito Haseyama, Shinichi Ito,Katsuya Fujimoto,Junichi Hashiguchi,Masao Nakagawa,Takanori Teshima
加载更多
作者统计
#Papers: 23
#Citation: 19
H-Index: 2
G-Index: 4
Sociability: 5
Diversity: 2
Activity: 9
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn